In our prior work, proglumide significantly decreased liver transaminase elevation in CDE-fed mice (20); therefore, proglumide may have protective properties in the NASH injury model independent of the CCK-BR. The gene discussed is CCKBR; the disease is metabolic dysfunction-associated steatohepatitis.